168 related articles for article (PubMed ID: 12749881)
1. Inhibition of HIV tat-TAR interactions by an antisense oligo-2'-O-methylribonucleoside methylphosphonate.
Hamma T; Saleh A; Huq I; Rana TM; Miller PS
Bioorg Med Chem Lett; 2003 Jun; 13(11):1845-8. PubMed ID: 12749881
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of alternating oligo-2'-O-methylribonucleoside methylphosphonates and their interactions with HIV TAR RNA.
Hamma T; Miller PS
Biochemistry; 1999 Nov; 38(46):15333-42. PubMed ID: 10563819
[TBL] [Abstract][Full Text] [Related]
3. Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkages.
Miller PS; Cassidy RA; Hamma T; Kondo NS
Pharmacol Ther; 2000 Mar; 85(3):159-63. PubMed ID: 10739870
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
[TBL] [Abstract][Full Text] [Related]
7. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
8. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
[TBL] [Abstract][Full Text] [Related]
9. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
10. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
[TBL] [Abstract][Full Text] [Related]
11. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
12. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Yang M
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
Jeang KT; Berkhout B
J Biol Chem; 1992 Sep; 267(25):17891-9. PubMed ID: 1517225
[TBL] [Abstract][Full Text] [Related]
15. 2'-O-methyl-RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription.
Darfeuille F; Arzumanov A; Gait MJ; Di Primo C; Toulmé JJ
Biochemistry; 2002 Oct; 41(40):12186-92. PubMed ID: 12356320
[TBL] [Abstract][Full Text] [Related]
16. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
17. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
[TBL] [Abstract][Full Text] [Related]
18. Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.
Alonso A; Cujec TP; Peterlin BM
J Virol; 1994 Oct; 68(10):6505-13. PubMed ID: 8083988
[TBL] [Abstract][Full Text] [Related]
19. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R; Kurabayashi M; Kedes L
AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
